Radiotherapy for Thymoma and Thymic Carcinoma

Clifton David Fuller; Douglas M. Housman; Charles R. Thomas

doi:10.1016/j.hoc.2008.03.012

Radiotherapy for Thymoma and Thymic Carcinoma

Clifton David Fuller, Douglas M. Housman, Charles R. Thomas

Radiation Oncology

Research output: Contribution to journal › Review article › peer-review

14 Scopus citations

Abstract

The role of radiotherapy for patients who have thymic neoplasms remains unclear. The low incidence of thymic malignancies, excellent outcome with complete resection, and limited body of evidence obfuscate the role of radiation therapy within the current multidisciplinary management of disease. Nonetheless, existing literature reports and novel radiotherapy techniques show increasing potential for integration of radiotherapy into the standard therapeutic milieu for carefully selected patient subpopulations.

Original language	English (US)
Pages (from-to)	489-507
Number of pages	19
Journal	Hematology/Oncology Clinics of North America
Volume	22
Issue number	3
DOIs	https://doi.org/10.1016/j.hoc.2008.03.012
State	Published - Jun 2008

ASJC Scopus subject areas

Hematology
Oncology

Access to Document

10.1016/j.hoc.2008.03.012

Cite this

@article{18f7a84512194950a046c86995efe5aa,

title = "Radiotherapy for Thymoma and Thymic Carcinoma",

abstract = "The role of radiotherapy for patients who have thymic neoplasms remains unclear. The low incidence of thymic malignancies, excellent outcome with complete resection, and limited body of evidence obfuscate the role of radiation therapy within the current multidisciplinary management of disease. Nonetheless, existing literature reports and novel radiotherapy techniques show increasing potential for integration of radiotherapy into the standard therapeutic milieu for carefully selected patient subpopulations.",

author = "Fuller, {Clifton David} and Housman, {Douglas M.} and Thomas, {Charles R.}",

year = "2008",

month = jun,

doi = "10.1016/j.hoc.2008.03.012",

language = "English (US)",

volume = "22",

pages = "489--507",

journal = "Hematology/Oncology Clinics of North America",

issn = "0889-8588",

publisher = "W.B. Saunders Ltd",

number = "3",

}

TY - JOUR

T1 - Radiotherapy for Thymoma and Thymic Carcinoma

AU - Fuller, Clifton David

AU - Housman, Douglas M.

AU - Thomas, Charles R.

PY - 2008/6

Y1 - 2008/6

N2 - The role of radiotherapy for patients who have thymic neoplasms remains unclear. The low incidence of thymic malignancies, excellent outcome with complete resection, and limited body of evidence obfuscate the role of radiation therapy within the current multidisciplinary management of disease. Nonetheless, existing literature reports and novel radiotherapy techniques show increasing potential for integration of radiotherapy into the standard therapeutic milieu for carefully selected patient subpopulations.

AB - The role of radiotherapy for patients who have thymic neoplasms remains unclear. The low incidence of thymic malignancies, excellent outcome with complete resection, and limited body of evidence obfuscate the role of radiation therapy within the current multidisciplinary management of disease. Nonetheless, existing literature reports and novel radiotherapy techniques show increasing potential for integration of radiotherapy into the standard therapeutic milieu for carefully selected patient subpopulations.

UR - http://www.scopus.com/inward/record.url?scp=44249102758&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=44249102758&partnerID=8YFLogxK

U2 - 10.1016/j.hoc.2008.03.012

DO - 10.1016/j.hoc.2008.03.012

M3 - Review article

C2 - 18514129

AN - SCOPUS:44249102758

SN - 0889-8588

VL - 22

SP - 489

EP - 507

JO - Hematology/Oncology Clinics of North America

JF - Hematology/Oncology Clinics of North America

IS - 3

ER -

Radiotherapy for Thymoma and Thymic Carcinoma

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this